Showing results (1251-1260 of 1,291) with videos related to

Sort By:
Pageof 130
Nature Immunology|May 10, 2016
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancersRahul Roychoudhuri, David Clever, Peng Li, et al.
Archives of General Psychiatry|July 7, 2010
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophreniaJames T R Walters, Aiden Corvin, Michael J Owen, et al.
Journal of Pathology Informatics|March 28, 2014
The 2013 symposium on pathology data integration and clinical decision support and the current state of fieldJason M Baron, Anand S Dighe, Ramy Arnaout, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 4, 2026
Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods studyO Boiko, K Barnard-Kelly, J Vercauteren, et al.
Journal of Clinical Pathology|January 31, 2006
The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisalD M Parham, D Coleman, S Kodikara, et al.
Blood|May 16, 2023
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cellsRadoslaw Kaczmarek, Annie R Piñeros, Paige E Patterson, et al.
Plos Biology|November 2, 2017
Uncovering protein-protein interactions through a team-based undergraduate biochemistry courseDavid L Cookmeyer, Emily S Winesett, Bashkim Kokona, et al.
ACS Chemical Biology|January 6, 2018
Dual Allosteric Inhibition of SHP2 PhosphataseMichelle Fodor, Edmund Price, Ping Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Breast Cancer Research and Treatment|October 4, 2024
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancerI M Browne, R A McLaughlin, C S Weadick, et al.
Pageof 130